Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 129 entries
Sorted by: Best Match Show Resources per page
Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR.

Iranian journal of pathology

Abdollahi A, Shakoori A, Khoshnevis H, Arabzadeh M, Dehghan Manshadi SA, Mohammadnejad E, Ghasemi D, Safari Aboksari M, Alizadeh S, Mehrtash V, Eftekhar-Javadi A, Safaei M.
PMID: 32944044
Iran J Pathol. 2020;15(4):313-319. doi: 10.30699/ijp.2020.127312.2387. Epub 2020 Jul 16.

BACKGROUND & OBJECTIVE: A simple approach to prevent close contact in healthcare settings during the COVID-19 outbreak is to train patients to collect their own nasopharyngeal and oropharyngeal swabs and deliver them to medical laboratories to have them processed....

Cite
Abdollahi A, Shakoori A, Khoshnevis H, et al. Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR. Iran J Pathol. 2020;15(4):313-319doi: 10.30699/ijp.2020.127312.2387.
Abdollahi, A., Shakoori, A., Khoshnevis, H., Arabzadeh, M., Dehghan Manshadi, S. A., Mohammadnejad, E., Ghasemi, D., Safari Aboksari, M., Alizadeh, S., Mehrtash, V., Eftekhar-Javadi, A., & Safaei, M. (2020). Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR. Iranian journal of pathology, 15(4), 313-319. https://doi.org/10.30699/ijp.2020.127312.2387
Abdollahi, Alireza, et al. "Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR." Iranian journal of pathology vol. 15,4 (2020): 313-319. doi: https://doi.org/10.30699/ijp.2020.127312.2387
Abdollahi A, Shakoori A, Khoshnevis H, Arabzadeh M, Dehghan Manshadi SA, Mohammadnejad E, Ghasemi D, Safari Aboksari M, Alizadeh S, Mehrtash V, Eftekhar-Javadi A, Safaei M. Comparison of Patient-collected and Lab Technician-collected Nasopharyngeal and Oropharyngeal Swabs for Detection of COVID-19 by RT-PCR. Iran J Pathol. 2020;15(4):313-319. doi: 10.30699/ijp.2020.127312.2387. Epub 2020 Jul 16. PMID: 32944044; PMCID: PMC7477688.
Copy Download .nbib Format: NLM
Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Cancer cell international

Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S.
PMID: 33478512
Cancer Cell Int. 2021 Jan 21;21(1):66. doi: 10.1186/s12935-021-01773-7.

Gastric cancer (GC) is one of the most common cancers with high malignancy. In spite of the great development in diagnostic tools and application of anti-tumor drugs, we have not witnessed a significant increase in the survival time of...

Cite
Ashrafizadeh M, Rafiei H, Mohammadinejad R, et al. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021;21(1):66doi: 10.1186/s12935-021-01773-7.
Ashrafizadeh, M., Rafiei, H., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2021). Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer cell international, 21(1), 66. https://doi.org/10.1186/s12935-021-01773-7
Ashrafizadeh, Milad, et al. "Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways." Cancer cell international vol. 21,1 (2021): 66. doi: https://doi.org/10.1186/s12935-021-01773-7
Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021 Jan 21;21(1):66. doi: 10.1186/s12935-021-01773-7. PMID: 33478512; PMCID: PMC7818776.
Copy Download .nbib Format: NLM
New Horizons in Hydrogels for Methotrexate Delivery.

Gels (Basel, Switzerland)

Dehshahri A, Kumar A, Madamsetty VS, Uzieliene I, Tavakol S, Azedi F, Fekri HS, Zarrabi A, Mohammadinejad R, Thakur VK.
PMID: 33396629
Gels. 2020 Dec 30;7(1). doi: 10.3390/gels7010002.

Since its first clinical application, methotrexate (MTX) has been widely used for the treatment of human diseases. Despite great advantages, some properties such as poor absorption, short plasma half-life and unpredictable bioavailability have led researchers to seek novel delivery...

Cite
Dehshahri A, Kumar A, Madamsetty VS, et al. New Horizons in Hydrogels for Methotrexate Delivery. Gels. 2020;7(1)doi: 10.3390/gels7010002.
Dehshahri, A., Kumar, A., Madamsetty, V. S., Uzieliene, I., Tavakol, S., Azedi, F., Fekri, H. S., Zarrabi, A., Mohammadinejad, R., & Thakur, V. K. (2020). New Horizons in Hydrogels for Methotrexate Delivery. Gels (Basel, Switzerland), 7(1), . https://doi.org/10.3390/gels7010002
Dehshahri, Ali, et al. "New Horizons in Hydrogels for Methotrexate Delivery." Gels (Basel, Switzerland) vol. 7,1 (2020). doi: https://doi.org/10.3390/gels7010002
Dehshahri A, Kumar A, Madamsetty VS, Uzieliene I, Tavakol S, Azedi F, Fekri HS, Zarrabi A, Mohammadinejad R, Thakur VK. New Horizons in Hydrogels for Methotrexate Delivery. Gels. 2020 Dec 30;7(1). doi: 10.3390/gels7010002. PMID: 33396629; PMCID: PMC7839000.
Copy Download .nbib Format: NLM
Development of detection methods for the diagnosis and analysis of highly toxic metal phosphides: A comprehensive and critical review.

Biotechnology and applied biochemistry

Mohammadinejad A, Rizi KS, Oskuee RK, Aryan E, Meshkat Z, Ulianas A, Rezayi M.
PMID: 33987922
Biotechnol Appl Biochem. 2021 May 14; doi: 10.1002/bab.2190. Epub 2021 May 14.

Metal phosphides, especially aluminum phosphide, and phosphine (PH

Cite
Mohammadinejad A, Rizi KS, Oskuee RK, et al. Development of detection methods for the diagnosis and analysis of highly toxic metal phosphides: A comprehensive and critical review. Biotechnol Appl Biochem. 2021;doi: 10.1002/bab.2190.
Mohammadinejad, A., Rizi, K. S., Oskuee, R. K., Aryan, E., Meshkat, Z., Ulianas, A., & Rezayi, M. (2021). Development of detection methods for the diagnosis and analysis of highly toxic metal phosphides: A comprehensive and critical review. Biotechnology and applied biochemistry, . https://doi.org/10.1002/bab.2190
Mohammadinejad, Arash, et al. "Development of detection methods for the diagnosis and analysis of highly toxic metal phosphides: A comprehensive and critical review." Biotechnology and applied biochemistry vol. (2021). doi: https://doi.org/10.1002/bab.2190
Mohammadinejad A, Rizi KS, Oskuee RK, Aryan E, Meshkat Z, Ulianas A, Rezayi M. Development of detection methods for the diagnosis and analysis of highly toxic metal phosphides: A comprehensive and critical review. Biotechnol Appl Biochem. 2021 May 14; doi: 10.1002/bab.2190. Epub 2021 May 14. PMID: 33987922.
Copy Download .nbib Format: NLM
Biosensors, microfluidics systems and lateral flow assays for circulating microRNA detection: A review.

Analytical biochemistry

Khandan-Nasab N, Askarian S, Mohammadinejad A, Aghaee-Bakhtiari SH, Mohajeri T, Kazemi Oskuee R.
PMID: 34619101
Anal Biochem. 2021 Nov 15;633:114406. doi: 10.1016/j.ab.2021.114406. Epub 2021 Oct 05.

MicroRNAs (miRNAs) are short RNA sequences found in eukaryotic cells and they are involved in several diseases pathogenesis including different types of cancers, metabolic and cardiovascular disorders. Thus, miRNAs circulating in serum, plasma, and other body fluids are employed...

Cite
Khandan-Nasab N, Askarian S, Mohammadinejad A, et al. Biosensors, microfluidics systems and lateral flow assays for circulating microRNA detection: A review. Anal Biochem. 2021;633:114406doi: 10.1016/j.ab.2021.114406.
Khandan-Nasab, N., Askarian, S., Mohammadinejad, A., Aghaee-Bakhtiari, S. H., Mohajeri, T., & Kazemi Oskuee, R. (2021). Biosensors, microfluidics systems and lateral flow assays for circulating microRNA detection: A review. Analytical biochemistry, 633114406. https://doi.org/10.1016/j.ab.2021.114406
Khandan-Nasab, Niloofar, et al. "Biosensors, microfluidics systems and lateral flow assays for circulating microRNA detection: A review." Analytical biochemistry vol. 633 (2021): 114406. doi: https://doi.org/10.1016/j.ab.2021.114406
Khandan-Nasab N, Askarian S, Mohammadinejad A, Aghaee-Bakhtiari SH, Mohajeri T, Kazemi Oskuee R. Biosensors, microfluidics systems and lateral flow assays for circulating microRNA detection: A review. Anal Biochem. 2021 Nov 15;633:114406. doi: 10.1016/j.ab.2021.114406. Epub 2021 Oct 05. PMID: 34619101.
Copy Download .nbib Format: NLM
Chitosan: A versatile bio-platform for breast cancer theranostics.

Journal of controlled release : official journal of the Controlled Release Society

Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P.
PMID: 34906606
J Control Release. 2021 Dec 11;341:733-752. doi: 10.1016/j.jconrel.2021.12.012. Epub 2021 Dec 11.

Breast cancer is considered one of the utmost neoplastic diseases globally, with a high death rate of patients. Over the last decades, many approaches have been studied to early diagnose and treat it, such as chemotherapy, hormone therapy, immunotherapy,...

Cite
Madamsetty VS, Tavakol S, Moghassemi S, et al. Chitosan: A versatile bio-platform for breast cancer theranostics. J Control Release. 2021;341:733-752doi: 10.1016/j.jconrel.2021.12.012.
Madamsetty, V. S., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Schneible, J. D., Fatemi, I., Shirvani, A., Zarrabi, A., Azedi, F., Dehshahri, A., Aghaei Afshar, A., Aghaabbasi, K., Pardakhty, A., Mohammadinejad, R., & Kesharwani, P. (2021). Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of controlled release : official journal of the Controlled Release Society, 341733-752. https://doi.org/10.1016/j.jconrel.2021.12.012
Madamsetty, Vijay Sagar, et al. "Chitosan: A versatile bio-platform for breast cancer theranostics." Journal of controlled release : official journal of the Controlled Release Society vol. 341 (2021): 733-752. doi: https://doi.org/10.1016/j.jconrel.2021.12.012
Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P. Chitosan: A versatile bio-platform for breast cancer theranostics. J Control Release. 2021 Dec 11;341:733-752. doi: 10.1016/j.jconrel.2021.12.012. Epub 2021 Dec 11. PMID: 34906606.
Copy Download .nbib Format: NLM
Pharmacological and Toxicological Properties of Eugenol.

Turkish journal of pharmaceutical sciences

Mohammadi Nejad S, Özgüneş H, Başaran N.
PMID: 32454614
Turk J Pharm Sci. 2017 Aug;14(2):201-206. doi: 10.4274/tjps.62207. Epub 2017 Aug 15.

Eugenol is a volatile phenolic constituent of clove essential oil obtained from

Cite
Mohammadi Nejad S, Özgüneş H, Başaran N. Pharmacological and Toxicological Properties of Eugenol. Turk J Pharm Sci. 2017;14(2):201-206doi: 10.4274/tjps.62207.
Mohammadi Nejad, S., Özgüneş, H., & Başaran, N. (2017). Pharmacological and Toxicological Properties of Eugenol. Turkish journal of pharmaceutical sciences, 14(2), 201-206. https://doi.org/10.4274/tjps.62207
Mohammadi Nejad, Solmaz, et al. "Pharmacological and Toxicological Properties of Eugenol." Turkish journal of pharmaceutical sciences vol. 14,2 (2017): 201-206. doi: https://doi.org/10.4274/tjps.62207
Mohammadi Nejad S, Özgüneş H, Başaran N. Pharmacological and Toxicological Properties of Eugenol. Turk J Pharm Sci. 2017 Aug;14(2):201-206. doi: 10.4274/tjps.62207. Epub 2017 Aug 15. PMID: 32454614; PMCID: PMC7227856.
Copy Download .nbib Format: NLM
Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line.

Advanced pharmaceutical bulletin

Asadi H, Orangi M, Shanehbandi D, Babaloo Z, Delazar A, Mohammadnejad L, Zare Shahneh F, Valiyari S, Baradaran B.
PMID: 25364662
Adv Pharm Bull. 2014 Oct;4:455-8. doi: 10.5681/apb.2014.067. Epub 2014 Aug 25.

PURPOSE: The present study, was aimed to assess the cytotoxic effects of Ornithogalum cuspidatum methanolic fractions on PC-3, prostate cancer cells and WEHI-164, Fibrosarcoma cells.METHODS: Methanolic fractions of O. cuspidatum were prepared using solid phase extraction and the cells...

Cite
Asadi H, Orangi M, Shanehbandi D, et al. Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line. Adv Pharm Bull. 2014;4:455-8doi: 10.5681/apb.2014.067.
Asadi, H., Orangi, M., Shanehbandi, D., Babaloo, Z., Delazar, A., Mohammadnejad, L., Zare Shahneh, F., Valiyari, S., & Baradaran, B. (2014). Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line. Advanced pharmaceutical bulletin, 4455-8. https://doi.org/10.5681/apb.2014.067
Asadi, Hamed, et al. "Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line." Advanced pharmaceutical bulletin vol. 4 (2014): 455-8. doi: https://doi.org/10.5681/apb.2014.067
Asadi H, Orangi M, Shanehbandi D, Babaloo Z, Delazar A, Mohammadnejad L, Zare Shahneh F, Valiyari S, Baradaran B. Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line. Adv Pharm Bull. 2014 Oct;4:455-8. doi: 10.5681/apb.2014.067. Epub 2014 Aug 25. PMID: 25364662; PMCID: PMC4213785.
Copy Download .nbib Format: NLM
Screening of anti-.

Royal Society open science

Shahryari S, Mohammadnejad P, Noghabi KA.
PMID: 34457318
R Soc Open Sci. 2021 Aug 18;8(8):201652. doi: 10.1098/rsos.201652. eCollection 2021 Aug.

Therapeutic options including last-line or combined antibiotic therapies for multi-drug-resistant strains of

Cite
Shahryari S, Mohammadnejad P, Noghabi KA. Screening of anti-. R Soc Open Sci. 2021;8(8):201652doi: 10.1098/rsos.201652.
Shahryari, S., Mohammadnejad, P., & Noghabi, K. A. (2021). Screening of anti-. Royal Society open science, 8(8), 201652. https://doi.org/10.1098/rsos.201652
Shahryari, Shahab, et al. "Screening of anti-." Royal Society open science vol. 8,8 (2021): 201652. doi: https://doi.org/10.1098/rsos.201652
Shahryari S, Mohammadnejad P, Noghabi KA. Screening of anti-. R Soc Open Sci. 2021 Aug 18;8(8):201652. doi: 10.1098/rsos.201652. eCollection 2021 Aug. PMID: 34457318; PMCID: PMC8371366.
Copy Download .nbib Format: NLM
Neonatal brain resting-state functional connectivity imaging modalities.

Photoacoustics

Mohammadi-Nejad AR, Mahmoudzadeh M, Hassanpour MS, Wallois F, Muzik O, Papadelis C, Hansen A, Soltanian-Zadeh H, Gelovani J, Nasiriavanaki M.
PMID: 29511627
Photoacoustics. 2018 Feb 02;10:1-19. doi: 10.1016/j.pacs.2018.01.003. eCollection 2018 Jun.

Infancy is the most critical period in human brain development. Studies demonstrate that subtle brain abnormalities during this state of life may greatly affect the developmental processes of the newborn infants. One of the rapidly developing methods for early...

Cite
Mohammadi-Nejad AR, Mahmoudzadeh M, Hassanpour MS, et al. Neonatal brain resting-state functional connectivity imaging modalities. Photoacoustics. 2018;10:1-19doi: 10.1016/j.pacs.2018.01.003.
Mohammadi-Nejad, A. R., Mahmoudzadeh, M., Hassanpour, M. S., Wallois, F., Muzik, O., Papadelis, C., Hansen, A., Soltanian-Zadeh, H., Gelovani, J., & Nasiriavanaki, M. (2018). Neonatal brain resting-state functional connectivity imaging modalities. Photoacoustics, 101-19. https://doi.org/10.1016/j.pacs.2018.01.003
Mohammadi-Nejad, Ali-Reza, et al. "Neonatal brain resting-state functional connectivity imaging modalities." Photoacoustics vol. 10 (2018): 1-19. doi: https://doi.org/10.1016/j.pacs.2018.01.003
Mohammadi-Nejad AR, Mahmoudzadeh M, Hassanpour MS, Wallois F, Muzik O, Papadelis C, Hansen A, Soltanian-Zadeh H, Gelovani J, Nasiriavanaki M. Neonatal brain resting-state functional connectivity imaging modalities. Photoacoustics. 2018 Feb 02;10:1-19. doi: 10.1016/j.pacs.2018.01.003. eCollection 2018 Jun. PMID: 29511627; PMCID: PMC5832677.
Copy Download .nbib Format: NLM
Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review.

Journal of advanced research

Mohammadinejad R, Dadashzadeh A, Moghassemi S, Ashrafizadeh M, Dehshahri A, Pardakhty A, Sassan H, Sohrevardi SM, Mandegary A.
PMID: 30828478
J Adv Res. 2019 Jan 18;18:81-93. doi: 10.1016/j.jare.2019.01.004. eCollection 2019 Jul.

Recently, carbon dots (CDs) have attracted great attention due to their superior properties, such as biocompatibility, fluorescence, high quantum yield, and uniform distribution. These characteristics make CDs interesting for bioimaging, therapeutic delivery, optogenetics, and theranostics. Photoluminescence (PL) properties enable...

Cite
Mohammadinejad R, Dadashzadeh A, Moghassemi S, et al. Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review. J Adv Res. 2019;18:81-93doi: 10.1016/j.jare.2019.01.004.
Mohammadinejad, R., Dadashzadeh, A., Moghassemi, S., Ashrafizadeh, M., Dehshahri, A., Pardakhty, A., Sassan, H., Sohrevardi, S. M., & Mandegary, A. (2019). Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review. Journal of advanced research, 1881-93. https://doi.org/10.1016/j.jare.2019.01.004
Mohammadinejad, Reza, et al. "Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review." Journal of advanced research vol. 18 (2019): 81-93. doi: https://doi.org/10.1016/j.jare.2019.01.004
Mohammadinejad R, Dadashzadeh A, Moghassemi S, Ashrafizadeh M, Dehshahri A, Pardakhty A, Sassan H, Sohrevardi SM, Mandegary A. Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review. J Adv Res. 2019 Jan 18;18:81-93. doi: 10.1016/j.jare.2019.01.004. eCollection 2019 Jul. PMID: 30828478; PMCID: PMC6383136.
Copy Download .nbib Format: NLM
Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.

Iranian journal of psychiatry

Esalatmanesh S, Biuseh M, Noorbala AA, Mostafavi SA, Rezaei F, Mesgarpour B, Mohammadinejad P, Akhondzadeh S.
PMID: 29062366
Iran J Psychiatry. 2017 Jul;12(3):154-162.

No abstract available.

Cite
Esalatmanesh S, Biuseh M, Noorbala AA, et al. Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial. Iran J Psychiatry. 2017;12(3):154-162
Esalatmanesh, S., Biuseh, M., Noorbala, A. A., Mostafavi, S. A., Rezaei, F., Mesgarpour, B., Mohammadinejad, P., & Akhondzadeh, S. (2017). Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial. Iranian journal of psychiatry, 12(3), 154-162.
Esalatmanesh, Sophia, et al. "Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial." Iranian journal of psychiatry vol. 12,3 (2017): 154-162.
Esalatmanesh S, Biuseh M, Noorbala AA, Mostafavi SA, Rezaei F, Mesgarpour B, Mohammadinejad P, Akhondzadeh S. Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial. Iran J Psychiatry. 2017 Jul;12(3):154-162. PMID: 29062366; PMCID: PMC5640576.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 129 entries